DELRAY BEACH, Fla., Oct. 31, 2025 /PRNewswire/ — According to MarketsandMarkets™, The agriculture biotechnology market is ...

Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Professor David Williams, a New Zealander working on gene therapy at UCLA, has warned that the Bill is “unfair to farmers” and based on false assumptions about precision and safety. He points to ...

The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasd ...

Despite challenges like high production costs and uneven regulations, the region is set to become a hub for cutting-edge ...

A single mutation in the YFT3 gene turns tomatoes yellow by disrupting a crucial pigment-producing enzyme. Researchers have discovered that a single genetic change in the YFT3 gene disrupts a vital ...

-- Posters will review product characterization and manufacturing data on T-knife’s lead program, TK-6302, a supercharged PRAME T cell receptor therapy that is advancing towards the clinic, with the ...